218 related articles for article (PubMed ID: 24106105)
1. HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery.
Almalik A; Day PJ; Tirelli N
Macromol Biosci; 2013 Dec; 13(12):1671-80. PubMed ID: 24106105
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation.
Almalik A; Donno R; Cadman CJ; Cellesi F; Day PJ; Tirelli N
J Control Release; 2013 Dec; 172(3):1142-50. PubMed ID: 24103813
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles.
Almalik A; Karimi S; Ouasti S; Donno R; Wandrey C; Day PJ; Tirelli N
Biomaterials; 2013 Jul; 34(21):5369-80. PubMed ID: 23615561
[TBL] [Abstract][Full Text] [Related]
4. CD44-Targeted Hyaluronic Acid-Coated Redox-Responsive Hyperbranched Poly(amido amine)/Plasmid DNA Ternary Nanoassemblies for Efficient Gene Delivery.
Gu J; Chen X; Ren X; Zhang X; Fang X; Sha X
Bioconjug Chem; 2016 Jul; 27(7):1723-36. PubMed ID: 27311558
[TBL] [Abstract][Full Text] [Related]
5. Nanocarriers for cytoplasmic delivery: cellular uptake and intracellular fate of chitosan and hyaluronic acid-coated chitosan nanoparticles in a phagocytic cell model.
Zaki NM; Nasti A; Tirelli N
Macromol Biosci; 2011 Dec; 11(12):1747-60. PubMed ID: 21954171
[TBL] [Abstract][Full Text] [Related]
6. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.
Lu HD; Zhao HQ; Wang K; Lv LL
Int J Pharm; 2011 Nov; 420(2):358-65. PubMed ID: 21911044
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.
Mizrahy S; Raz SR; Hasgaard M; Liu H; Soffer-Tsur N; Cohen K; Dvash R; Landsman-Milo D; Bremer MG; Moghimi SM; Peer D
J Control Release; 2011 Dec; 156(2):231-8. PubMed ID: 21745506
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-hyaluronic acid nanoparticles for gene silencing: the role of hyaluronic acid on the nanoparticles' formation and activity.
Al-Qadi S; Alatorre-Meda M; Zaghloul EM; Taboada P; Remunán-López C
Colloids Surf B Biointerfaces; 2013 Mar; 103():615-23. PubMed ID: 23274155
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44.
Wang T; Hou J; Su C; Zhao L; Shi Y
J Nanobiotechnology; 2017 Jan; 15(1):7. PubMed ID: 28068992
[TBL] [Abstract][Full Text] [Related]
10. Effect of preparation parameters on ultra low molecular weight chitosan/hyaluronic acid nanoparticles.
Nazeri N; Avadi MR; Faramarzi MA; Safarian S; Tavoosidana G; Khoshayand MR; Amani A
Int J Biol Macromol; 2013 Nov; 62():642-6. PubMed ID: 24099942
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
[TBL] [Abstract][Full Text] [Related]
12. Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles.
Mizrahy S; Goldsmith M; Leviatan-Ben-Arye S; Kisin-Finfer E; Redy O; Srinivasan S; Shabat D; Godin B; Peer D
Nanoscale; 2014 Apr; 6(7):3742-52. PubMed ID: 24569711
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes.
Choi KM; Jang M; Kim JH; Ahn HJ
Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled nanoparticles based on amphiphilic chitosan derivative and hyaluronic acid for gene delivery.
Liu Y; Kong M; Cheng XJ; Wang QQ; Jiang LM; Chen XG
Carbohydr Polym; 2013 Apr; 94(1):309-16. PubMed ID: 23544543
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo gene delivery using chitosan/hyaluronic acid nanoparticles: Influences of molecular mass of hyaluronic acid and lyophilization on transfection efficiency.
Sato T; Nakata M; Yang Z; Torizuka Y; Kishimoto S; Ishihara M
J Gene Med; 2017 Aug; 19(8):. PubMed ID: 28667693
[TBL] [Abstract][Full Text] [Related]
16. Chitosan/Hyaluronic Acid Nanoparticles: Rational Design Revisited for RNA Delivery.
Lallana E; Rios de la Rosa JM; Tirella A; Pelliccia M; Gennari A; Stratford IJ; Puri S; Ashford M; Tirelli N
Mol Pharm; 2017 Jul; 14(7):2422-2436. PubMed ID: 28597662
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
[TBL] [Abstract][Full Text] [Related]
18. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
19. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
de la Fuente M; Seijo B; Alonso MJ
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2016-24. PubMed ID: 18436835
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.
Ping Y; Liu C; Zhang Z; Liu KL; Chen J; Li J
Biomaterials; 2011 Nov; 32(32):8328-41. PubMed ID: 21840593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]